Evidence map›Paper›PMID 18417529›Full record

ArticleThe Journal of endocrinology2008

Identification of an INSM1-binding site in the insulin promoter: negative regulation of the insulin gene transcription.

Hong-Wei Wang, Michelle Muguira, Wei-Dong Liu, Tao Zhang, Chiachen Chen, Rebecca Aucoin, Mary B Breslin, Michael S Lan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of endocrinology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. AZoological research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hong-Wei WangThe Research Institute for Children, Children's Hospital, 200 Henry Clay Avenue, New Orleans, Louisiana 70118, USA.
Michelle Muguira
Wei-Dong Liu
Tao Zhang
Chiachen Chen
Rebecca Aucoin
Mary B Breslin
Michael S Lan
Children's Hospital of New Orleans · USPediatrics and Genetics · USLouisiana State University Health Sciences Center New Orleans · US

Funding

Transcription Factors in Neuroendocrine DifferentiationR01DK061436 · NIDDK · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI LAN, MICHAEL S · 2003 to 2009
$1.5M
NIDDK NIH HHS DK61436NIDDK NIH HHS R01 DK061436
6 · The paper itself

Abstract

In this study, an insulinoma-associated antigen-1 (INSM1)-binding site in the proximal promoter sequence of the insulin gene was identified. The co-transfection of INSM1 with rat insulin I/II promoter-driven reporter genes exhibited a 40-50% inhibitory effect on the reporter activity. Mutational experiments were performed by introducing a substitution, GG to AT, into the INSM1 core binding site of the rat insulin I/II promoters. The mutated insulin promoter exhibited a three- to 20-fold increase in the promoter activity over the wild-type promoter in several insulinoma cell lines. Moreover, INSM1 overexpression exhibited no inhibitory effect on the mutated insulin promoter. Chromatin immunoprecipitation assays using beta TC-1, mouse fetal pancreas, and Ad-INSM1-transduced human islets demonstrated that INSM1 occupies the endogenous insulin promoter sequence containing the INSM1-binding site in vivo. The binding of the INSM1 to the insulin promoter could suppress approximately 50% of insulin message in human islets. The mechanism for transcriptional repression of the insulin gene by INSM1 is mediated through the recruitment of cyclin D1 and histone deacetylase-3 to the insulin promoter. Anti-INSM1 or anti-cyclin D1 morpholino treatment of fetal mouse pancreas enhances the insulin promoter activity. These data strongly support the view that INSM1 is a new zinc-finger transcription factor that modulates insulin gene transcription during early pancreas development.

Indexed as

Promoter Regions, GeneticAnimalsBinding SitesCell Line, TumorCyclin D1DNA-Binding ProteinsGene Expression RegulationHistone Deacetylase 3Histone DeacetylasesHumansInsulinMicePancreasRatsRepressor ProteinsTranscription, GeneticCCND1 protein, humanCyclin D1DNA-Binding ProteinsHistone Deacetylase 3Histone DeacetylasesINSM1 protein, humanInsulinRepressor Proteins

Identifiers

PMID18417529
PMCPMC2529182
OpenAlexW2119399069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.